We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Advice for medical professionals to follow when assessing drivers with diabetes mellitus.
Device-specific guidance for manufacturers on reporting adverse incidents under the vigilance system
You may need to tell DVLA if you have diabetes, depending on the treatment you're getting
Advice for healthcare professionals on how to use blood glucose meters safely and effectively.
Information for healthcare professionals.
Scientific opinion from the UK Nutrition and Health Claims Committee (UKNHCC) for the substantiation of an Article 14(1)(a) health claim: Morus alba leaf extract and blood glucose levels.
Data analysis was performed using the chi-square test and multivariate logistic regression
This study reported high prevalence, especially of undiagnosed cases amongst adults, most have uncontrolled blood sugar levels
The new presentation of Mounjaro gives four doses for once-a-week treatment over a month.
An overview of the NHS diabetic eye screening (DES) programme, its services and contact information.
Information and guidance on a range of medical devices for users and patients.
We remind healthcare professionals that accidental use of glucose-containing solutions as flush fluid for arterial lines may contaminate blood samples and result in falsely high glucose readings. This may lead to inappropriate insulin administration and subsequent hypoglycaemia. Healthcare professionals should...
A retrospective cohort study involving a review of records maintained under the National Diabetes Control Programme
Falsified, potentially harmful Ozempic▼ and Saxenda products have been found in the UK.
How to use a cost effectiveness analysis to evaluate your digital health product.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.